HomeTOP STORIESGoodRx projects $790M-$805M revenue and $240M-$250M adjusted EBITDA as Pharma Direct targets... GoodRx projects $790M-$805M revenue and $240M-$250M adjusted EBITDA as Pharma Direct targets 70%+ growth By rogerjudd August 6, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleTurtle Beach reaffirms 2026 revenue $335M-$355M outlook as it targets mid- to high 30% gross marginNext articleAirbnb signals at least mid-teens 2026 revenue growth while guiding Q3 revenue to $4.69B-$4.77B latest articles National Healthcare declares $0.67 dividend BTB Real Estate Investment Trust declares CAD 0.025 dividend Meta Ordered to Pay $567 Million Fine by New Mexico Judge Retired police chief helps subdue passenger after alleged midair outburst over alcohol cutoff Funko raises full-year adjusted EBITDA guidance to $100M-$110M amid $25M tariff credit Genpact signals at least 25% 2026 Advanced Technology Solutions growth as it targets over $1B in agentic TCV explore more National Healthcare declares $0.67 dividend BTB Real Estate Investment Trust declares CAD 0.025 dividend Meta Ordered to Pay $567 Million Fine by New Mexico Judge Retired police chief helps subdue passenger after alleged midair outburst over alcohol cutoff Funko raises full-year adjusted EBITDA guidance to $100M-$110M amid $25M tariff credit Genpact signals at least 25% 2026 Advanced Technology Solutions growth as it targets over $1B in agentic TCV
